Boston Scientific Corporation: Heart Diseases trials

The registry lists 11 Heart Diseases studies with Boston Scientific Corporation as lead sponsor. 1 are open to participants now and 1 have results posted.

No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• BoStOn SCientific Rhythm MAnagemenT REgiStryRecruitingNCT04823663
• APPROPRIATE - Rate Adaptive Pacing SensorTerminatedNCT00757666Not applicableResults posted
• VITALYST Early Feasibility Study in High-Risk PCI Patients (VITALYST EFS)CompletedNCT06132568Not applicable
• Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial FibrillationActive, not recruitingNCT06096337Not applicable
• A U.S Post Approval Study Evaluating the SYNERGY XLV (MEGATRON) Stent SystemCompletedNCT04807439
• A Clinical Trial to Confirm Safety & Effectiveness of the SYNERGY 4.50 mm and 5.00 mm Stent for Treatment of Atherosclerotic Lesion(s)CompletedNCT03875651
• Precision Event Monitoring for Patients With Heart Failure Using HeartLogicCompletedNCT03579641
• Carotid Filtration During Endovascular Aortic Valve ImplantationCompletedNCT01484249Not applicable
• High Septal Pacing for Cardiac Resynchronization TherapyTerminatedNCT01325480
• TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System European Post-Approval Surveillance Study (TE-Prove)CompletedNCT01242696
• PROMUS™ Element™ Everolimus-Eluting Coronary Stent System European Post-Approval Surveillance StudyCompletedNCT01148329